Related Experiment Video
Updated: May 30, 2026

Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery
Published on: September 30, 2021
[Harry Dorchy and pediatric diabetology]
1New England Diabetes and Endocrinology Center (NEDEC), Waltham, MA 02451-1136, USA. stubrink@aol.com
Insights
Professor Harry Dorchy, a leader in pediatric diabetes care, is retiring after a distinguished 40-year career. His work has significantly advanced the treatment and understanding of diabetes in children and adolescents globally.
Area of Science:
- Pediatric Endocrinology
- Diabetology
- Clinical Research
Background:
- Professor Harry Dorchy's career spans 40 years, focusing on pediatric diabetes care and research.
- He co-established a legacy of clinical care and innovative thinking for young people with diabetes.
- Dr. Dorchy's patients at Queen Fabiola University Children's Hospital demonstrate exceptional glycemic control.
Discussion:
- Dr. Dorchy's research encompasses screening for complications, diet, physical activity, glycemic control, and quality of life in pediatric diabetes.
- His work has contributed to understanding genetics, immunology, and specific types of diabetes in youth.
- He has been a key figure in international collaborations, including the Hvidoere International Study Group.
Key Insights:
- Dr. Dorchy's patient cohort achieved the lowest hemoglobin A1c levels within the Hvidoere International Study Group, indicating superior diabetes management.
- This success was achieved without excessive hypoglycemia, highlighting a balanced approach to treatment.
- His extensive publication record reflects a deep and impactful contribution to the field.
Outlook:
- Professor Dorchy's mentorship and teaching have influenced the next generation of pediatric diabetologists.
- His collaborative efforts in Romania have fostered international knowledge exchange in diabetes care.
- The legacy of his research and clinical practice will continue to shape pediatric diabetes management worldwide.
Abstract:
"Monsieur Le Professor Harry Dorchy is retiring". He has had a brilliant 40 year career since receiving his medical degree from the Free University of Brussels in 1969 and his PhD--entitled " Contribution a l'etude du diabète de l'enfant et de l'adolescent "--in 1981 from the same illustrious university. He had the great fortune to connect with his mentor, Professor Helmut Jean Loeb, and for many years, the two of them cared for young people with diabetes in Brussels and worked closely to establish a remarkable legacy of clinical care, research and innovative thinking about how young children in Belgium--in fact, around the world--, ought to be considered and treated. At the moment of his official retirement, he has an active patient census of 792 patients, 442 under the age of 18 years, at the Queen Fabiola University Children's Hospital in Brussels. As a member of the Hvidoere International Study Group on Childhood Diabetes, Dr Dorchy's patients have the great honor of being the most successful study cohort: those with the lowest (ie. best) levels of hemoglobin A1c. And they do so without excessive hypoglycemia! Dr Dorchy has had 490 publications as an author in his scientific career, 335 as first author. Dr Dorchy's research has complemented his superb work as a clinician : screening for subclinical complications, normal and flexible diet, physical activity, glycemic control and insulin treatment, quality of life, genetics and immunology, specific types of diabetes, etc. Since 1996, with his pediatric diabetologist comrade, Professor Stuart Brink from Boston, he has traveled annually to Romania to help organize, administer and teach at an annual ISPAD-Timisoara Pediatric and Adolescent Diabetes Post-Graduate Course with Professor Viorel Serban.
Related Concept Videos
Diabetes Insipidus I: Introduction
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Nephropathy
Diabetes Mellitus: Type 2 and Gestational
Diabetic Ketoacidosis l: Introduction

